Develops biomimetic nucleic acid polymers and sustainable bioprocesses for RNA therapeutics and research, combining DNA-binding and RNA-folding functions to address undruggable targets. Targets researchers and therapeutic developers with SELEX-compatible materials that handle >50-base constructs and address primer design, temperature, and RNase/DNase challenges.